CA Stock MarketDetailed Quotes

HLS HLS Therapeutics Inc

Watchlist
  • 3.840
  • +0.130+3.50%
15min DelayMarket Closed Dec 20 16:00 ET
122.09MMarket Cap-4.12P/E (TTM)

About HLS Therapeutics Inc Company

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.

Company Profile

SymbolHLS
Company NameHLS Therapeutics Inc
Founded2014
MarketTSE
Employees90
Fiscal Year Ends12-31
Address10 Carlson Court Suite 701
CityEtobicoke
CountryCAN
Zip CodeM9W 6L2
Phone+1 647 495-9000

Company Executives

  • Name
  • Position
  • Salary
  • Craig Stuart Millian
  • Director and Chief Executive Officer
  • --
  • John Hanna
  • Interim Chief Financial Officer and Director
  • --
  • Dawn Edinboro
  • Vice President; General Manager of Heritage Life Sciences (Barbados) Inc.
  • --
  • Dr. Jason A. Gross,PhD
  • Vice President, Scientific Affairs
  • --
  • Patricia Perry
  • Vice President, Human Resource
  • --
  • Ryan C. Lennox
  • Senior Vice President, Legal, Human Resource and Compliance and Corporate Secretary
  • --
  • Brian T. Walsh
  • Senior Vice President, Commercial
  • --
  • David Spence
  • Vice President and Corporate Controller
  • --
  • John L. Welborn, Jr
  • Chairman of the Board
  • --
  • Laura A. Brege
  • Independent Director
  • --
  • Christian Roy
  • Independent Director
  • --
  • Kyle Dempsey
  • Independent Director
  • --
  • Rodney Hill
  • Independent Director
  • --
  • Norma Beauchamp
  • Independent Director
  • --
Heat List
CA
Overall
Symbol
Price
% Chg

No Data